On today's STOP TRADING segment on CNBC, Jim Cramer talked about some of his ethanol plays. As far as the crop report, Cramer thinks they aren't focusing on the secular trends. He likes these regardless of the crop acreage report:
Archer-Daniels-Midland (NYSE: ADM)
Deere & Co. (NYSE: DE)
Bunge Ltd. (NYSE: BG)
Monsanto Co. (NYSE: MON)
He said NO on the pure plays like Pacific Ethanol (NASDAQ: PEIX) or the Andersons Inc. (NYSE: ANDE) because you can buy best-of-breed names. On oil Cramer addressed the Iran issue, and the Oil Stocks are acting like there will be a resolution to Iran very soon. The stocks are telling you that there will be a breakthrough this weekend and that is why they are down.
Cramer brought up Take-Two Interactive Software (NYSE: TTWO) and said that GTA may get them out of the hole, but that is still a problem-stock with uncertainty. QUALCOMM Inc. (NYSE: QCOM) is a persistent stock. Cramer noted the company has already signaled a good quarter, but he said it is up on window dressing and right now it's a "Don't Buy" until it comes in.
Last updated: May 21, 2012: 10:27 AM
Hot Stocks
DailyFinance Headlines
- Your 7-Step Midyear Money Checkup
- Elon Musk Boldly Goes Where No Entrepreneur Could Afford to Go Before
- The Real Facebook Investing Story: How Advisers and Investors Are Using Social Media
- Facebook Real-Time Wealth Tracker: What Are the Big Investors' Stakes Worth?
- 28 Crazy Facts You Didn't Know About Facebook
Benzinga Headlines
- Sears to Shed Clothing
- Is Cisco About to Buy NDS?
- Current Account, Import Prices Says US is Buying Goods on the Cheap
- Goldman Sachs Executive Director Calls the Bank "Toxic" on the Way Out
- BB&T Acquires BankAtlantic
TheFlyOnTheWall.com Headlines
- Campbell Soup reports U.S. wet soup market share 59.6% in Q3
- Campbell Soup reports Q3 advertising and promotion spending up 13%
- Campbell Soup says taking another price increase in condensed soup in June
- Sturm, Ruger initiated with a Sell at Off Wall Street Research (pre-open)
- Zebra Tech gaps down, support is at $33.66 pivot low
BioHealth Investor Headlines
- Shouldn’t VIVUS Raise Capital Now? (VVUS)
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
WalletPop Headlines
- Your 7-Step Midyear Money Checkup
- Elon Musk Boldly Goes Where No Entrepreneur Could Afford to Go Before
- The Real Facebook Investing Story: How Advisers and Investors Are Using Social Media
- Facebook Real-Time Wealth Tracker: What Are the Big Investors' Stakes Worth?
- 28 Crazy Facts You Didn't Know About Facebook
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
PC Upgrades on Byte-Size Budgets -- Savings Experiment
Weird-Mart: Tales of the Bizarre from the Walmart Aisles

